Zai Lab Limited (ZLAB) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Zai Lab Limited (ZLAB) closed at USD 22.50 on 2026-10-14, a change of -11.5 % over the past year, with a market capitalization of USD 2.64B.

Zai Lab Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Zai Lab Limited key figures

Previous close

USD 22.50 (2026-10-14)

1-year change

-11.5 %

Market cap

USD 2.64B

Enterprise value

USD 2.28B

P/E ratio (trailing)

-13.59

P/E ratio (forward)

-11.14

EPS (trailing)

-1.73

EPS (forward)

-2.11

PEG ratio

n/a

Price to book

4.35

Revenue growth

-3.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

8.38

Employees

1,784

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Zai Lab Limited

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Zai Lab Limited and compare it with other stocks.